AbbVie News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

20.10.20	ABBV Seeks Expanded Approval Of Rinvoq, APTX Cheered By PTSD Data, ENDP Snaps Up BSTC, LQDA On Watch (RTTNews)
19.10.20	Roche: FDA Approves Venclexta Combinations For Treatment Of Acute Myeloid Leukaemia (RTTNews)
07.10.20	Allergan Aesthetics To Acquire Luminera's Dermal Filler Business - Quick Facts (RTTNews)
01.10.20	AbbVie: New Brunswick, British Columbia List SKYRIZI On Its Provincial Formulary (RTTNews)
28.09.20	AbbVie: FDA Grants Orphan Drug & Fast Track Designations For Elezanumab (RTTNews)
04.09.20	AbbVie To License I-Mab's Anti-CD47 Monoclonal Antibody Lemzoparlimab (RTTNews)
27.08.20	UroGen Pharma: Phase 2 APOLLO Clinical Trial Did Not Meet Primary Endpoint (RTTNews)
04.08.20	ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec. (RTTNews)
03.08.20	AbbVie, Amgen, Takeda Pharma Enroll First Patients In I-SPY COVID Trial (RTTNews)
31.07.20	AbbVie Issues Combined Company 2020 Earnings Guidance - Quick Facts (RTTNews)
31.07.20	AbbVie Q2 adjusted earnings Beat Estimates (RTTNews)
29.07.20	AbbVie Announces Positive Late-stage Data For Atogepant In Migraine Prevention (RTTNews)
21.07.20	AbbVie: RINVOQ Meets Endpoints In Second Phase 3 Study For Atopic Dermatitis (RTTNews)
21.07.20	Gilead To Acquire 49.9% Equity Interest In Tizona - Quick Facts (RTTNews)
10.07.20	Botox, Keytruda Get FDA Approval For New Uses, BVXV Abuzz, First Droopy Eyelid Treatment Is Here (RTTNews)
10.07.20	AbbVie : FDA Oks Expanded BOTOX Label For Treatment Of Pediatric Patients With Spasticity (RTTNews)
26.06.20	AbbVie: FDA Issues Complete Response Letter To BLA For Abicipar Pegol (RTTNews)
23.06.20	AbbVie Says FDA To Review SNDA For IMBRUVICA In Combination With Rituximab - Quick Facts (RTTNews)
22.06.20	Allergan Files SBLA To Extend Use Of BOTOX For Patients 5 To 17 Years Old (RTTNews)
19.06.20	FDA Nod For EPZM, RARE, Court Rules In MYL's Favor, Ocuphire To Hop Onto Nasdaq, ALPN Soars (RTTNews)
18.06.20	Stock Alert: Alpine Immune Jumps 100% After Inking Deal With AbbVie (RTTNews)
18.06.20	AbbVie's Rinvoq Shows Improvement In Skin Clearance And Itch In Phase 3 Study For Atopic Dermatitis (RTTNews)
18.06.20	Alpine Immune, AbbVie Enter Into Option And License Deal For ALPN-101 (RTTNews)
10.06.20	AbbVie Signs Broad Collaboration Agreement With Denmark's Genmab - Quick Facts (RTTNews)
30.05.20	FDA Oks AbbVie's Oriahnn To Treat Heavy Menstrual Bleeding Associated With Fibroids In Women (RTTNews)
27.05.20	Ironwood, AbbVie To Discontinue Development Of MD-7246 - Quick Facts (RTTNews)
07.05.20	Salesforce.com To Replace Allergan In S&P100 (RTTNews)
01.05.20	AbbVie Confirms Standalone 2020 Adj. EPS Guidance - Quick Facts (RTTNews)
01.05.20	AbbVie Q1 adjusted earnings Beat Estimates (RTTNews)
27.04.20	Dr. Reddy's Labs Launches Fenofibrate Tablets In U.S. (RTTNews)
06.04.20	New Drugs Approved In The Month Of March (RTTNews)
23.03.20	Genentech's Late-stage Study On Aggressive Leukemia Meets Primary Endpoints (RTTNews)
12.03.20	Roche : EC Oks Venclyxto-Gazyvaro For Adults With Chronic Lymphocytic Leukaemia (RTTNews)
09.03.20	AbbVie: Chinese Media Reports Claim HIV Medicine Effective In COVID-19 Treatment (RTTNews)
06.03.20	AbbVie : EU Approves Change To Marketing Authorization For Maviret (RTTNews)
27.02.20	Fighting The Deadly Coronavirus (RTTNews)
07.02.20	Stock Alert: AbbVie Ascends 5% (RTTNews)
07.02.20	AbbVie Issues FY20 Outlook - Quick Facts (RTTNews)
07.02.20	AbbVie Q4 adjusted earnings Beat Estimates (RTTNews)
05.02.20	AbbVie: RINVOQ Meets Endpoints In Phase 3 Study In Psoriatic Arthritis (RTTNews)
31.01.20	AbbVie Reports CHMP Positive Opinion For VENCLYXTO - Quick Facts (RTTNews)
27.01.20	Allergan To Sell Brazikumab To AstraZeneca, Zenpep To Nestle Under AbbVie Merger (RTTNews)
14.01.20	AbbVie : Late-stage Plaque Psoriasis Study Meets Primary & Secondary Endpoints (RTTNews)
08.01.20	AbbVie To Create New Global Business Upon Completion Of Allergan Acquisition (RTTNews)
18.11.19	Pfizer: FDA Approves ABRILADA As Biosimilar To Humira - Quick Facts (RTTNews)
01.11.19	AbbVie Boosts FY19 Adj. EPS Outlook; Boosts Dividend 10.2% - Quick Facts (RTTNews)
01.11.19	Novartis: Cosentyx Shows Positive Results Vs Humira In Psoriatic Arthritis Trial (RTTNews)
14.10.19	Allergan Shareholders Oks Acquisition By AbbVie (RTTNews)
30.09.19	FTC Seeks Addl Information On AbbVie-Allergan $63 Bln Deal (RTTNews)
27.09.19	AbbVie Receives FDA Approval Of MAVYRET (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

15.01.25		Pluszeichen in New York: S&P 500 zum Ende des Mittwochshandels in der Gewinnzone
15.01.25		Börse New York in Grün: S&P 500 legt zu
15.01.25		Freundlicher Handel in New York: So performt der S&P 500 am Mittag
15.01.25		Aufschläge in New York: S&P 500 zum Start stärker
11.11.24		Börse New York in Grün: S&P 500 zum Handelsende freundlich
11.11.24		Optimismus in New York: S&P 500 am Nachmittag mit Kursplus
11.11.24		NYSE-Handel: S&P 500 mittags freundlich
11.11.24		Freundlicher Handel: Börsianer lassen S&P 500 zum Start des Montagshandels steigen

15.01.25

Pluszeichen in New York: S&P 500 zum Ende des Mittwochshandels in der Gewinnzone

15.01.25

Börse New York in Grün: S&P 500 legt zu

15.01.25

Freundlicher Handel in New York: So performt der S&P 500 am Mittag

15.01.25

Aufschläge in New York: S&P 500 zum Start stärker

11.11.24

Börse New York in Grün: S&P 500 zum Handelsende freundlich

11.11.24

Optimismus in New York: S&P 500 am Nachmittag mit Kursplus

11.11.24

NYSE-Handel: S&P 500 mittags freundlich

11.11.24

Freundlicher Handel: Börsianer lassen S&P 500 zum Start des Montagshandels steigen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Kuehne+Nagel Int	206.70	2.43 %	K V
UBS Group	31.75	1.99 %	K V
Lonza Grp	563.20	1.59 %	K V
Sika	227.20	1.16 %	K V
Alcon	77.98	1.01 %	K V
Swisscom	512.50	0.00 %	K V
Novartis	89.23	-0.10 %	K V
Swiss Re	135.60	-0.18 %	K V
Swiss Life Hldg	721.80	-0.50 %	K V
Zurich Insur Gr	530.40	-1.67 %	K V

Nachrichten zu AbbVie Inc

Aktien Top/Flop

AbbVie Peer Group Nachrichten

Meistgelesene Nachrichten